Global Liquid Biopsy Market Analysis, Trends, Market Size & Forecasts 2016-2024, With a Projected CAGR of 21.1% - ResearchAndMarkets.com

DUBLIN--()--The "Liquid Biopsy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global liquid biopsy market to grow with a CAGR of 21.1% over the forecast period of 2018-2024.

The analysis of non-solid biological tissue, mainly blood is known as liquid biopsy or as fluid biopsy. This type of technique is mainly used as a diagnostic and monitoring tool for diseases such as cancer. FDA has validated and approved liquid biopsy for circulating tumor cells as a useful prognostic method for various types of cancer. Liquid biopsy tests are done to understand the molecular aspects of cancer across the healthcare and research settings, such as physicians, pathological, hospitals, and research laboratories. It is a harmless blood test that will not damage the healthy tissues.

The increasing incidences of the cancer worldwide is likely to drive the growth of the market. Additionally, easy and non-invasive entrance to the tumor genome, early cancer diagnosis & detection and technology advancement and novel clinical trials for research and development is likely to propel the growth of the market. On the other hand, the lack of skilled professional to take the blood sample is likely to hamper the growth of the market.

Among the geographies, North America is expected to be largest market for liquid biopsy followed by Europe due to recent regulatory approvals by CE for commercial use of liquid biopsy tests in this region. In addition, adoption of technologically advanced products and increasing research and development funding/investments is likely to drive the growth in this region.

Companies Mentioned

  • Exosome Diagnostics
  • A Roche Molecular Diagnostics
  • QIAGEN
  • Thermo Fisher Scientific
  • CellMax Life
  • Chronix Biomedical
  • Epic Sciences
  • Bio-Rad Laboratories
  • Agena Bioscience
  • RainDance Technologies

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Liquid Biopsy Market Overview

4. Global Liquid Biopsy Market by Product

5. Global Liquid Biopsy Market by End-User

6. Global Liquid Biopsy Market by Region 2018-2024

7. Company Covered

For more information about this report visit https://www.researchandmarkets.com/research/r589ds/global_liquid?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics